# Use of F-652 in Patients With Alcoholic Hepatitis

> **NCT02655510** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 18 (actual)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** F-652

## Key facts

- **NCT ID:** NCT02655510
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-09-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655510, "Use of F-652 in Patients With Alcoholic Hepatitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02655510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*